Brensocatib, Potential Bronchiectasis Therapy, to Enter COVID-19 Trial
News
Brensocatib, an oral investigational therapy being developed to treat bronchiectasis, will be tested in people with a severe COVID-19 infection in an upcoming clinical trial, Insmed, its developer, announced. The trial, ... Read more